the antihypertensive efficacy , lipid effects , and safety of doxazosin , a selective alpha 1-inhibitor for the reduction of coronary heart disease ( chd ) risk in hypertensive patients , was assessed in a general medical practice setting .
C0018799
the
C0018787
heart